Jushi Group: Stock price experiences severe abnormal fluctuations, indicating multiple investment risks.

HollyChem announced that from May 22 to July 3, 2026, the closing price of the company's stock has deviated by more than 200%, indicating a serious abnormal fluctuation. In 2025, the company's revenue was 3.909 billion yuan, a year-on-year decrease of 3.66%, with a net loss of 155 million yuan; in the first quarter of 2026, the revenue was 781 million yuan, a year-on-year decrease of 29.57%, with a net loss of 60 million yuan. The company's price-to-book ratio is higher than its industry peers, and it is still in a deficit. There is uncertainty in completing the equity incentive goals, and projects like photomask are still in the early research and development stage. Investors are reminded to pay attention to the risks of trading, valuation, and performance.